logo
Introduction
Coagulation markers and outcomes in acute coronary syndromes
Pathobiology of thrombin in acute coronary syndromes
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: Pathophysiologic foundation and clinical findings
Relation between inhibition of platelet aggregation and clinical outcomes
Progress in point-of-care laboratory testing for assessing platelet function
The future of antithrombotic and antiplatelet therapy for ischemic heart disease